Gene · 8846
Papers2,913
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,913
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development and validation of a novel prognostic signature based on m6A/m5C/m1A-related genes in hepatocellular carcinoma. | BMC Med Genomics | 2023 | 37525171 | PubTator, text mining | PubMed |
| The therapeutic targets of N6-methyladenosine (m6A) modifications on tumor radioresistance. | Discov Oncol | 2023 | 37522921 | PubTator, text mining | PubMed |
| Mitochondrial epigenetics in aging and cardiovascular diseases. | Front Cardiovasc Med | 2023 | 37522089 | PubTator, text mining | PubMed |
| Microaerobic degradation of crude oil and long chain alkanes by a new Rhodococcus strain from Gulf of Mexico. | World J Microbiol Biotechnol | 2023 | 37515608 | PubTator, text mining | PubMed |
| Infection Meets Inflammation: N6-Methyladenosine, an Internal Messenger RNA Modification as a Tool for Pharmacological Regulation of Host-Pathogen Interactions. | Biomolecules | 2023 | 37509095 | PubTator, text mining | PubMed |
| Individual Contributions of Amido Acid Residues Tyr122, Ile168, and Asp173 to the Activity and Substrate Specificity of Human DNA Dioxygenase ABH2. | Cells | 2023 | 37508504 | PubTator, text mining | PubMed |
| ALKBH4 is a novel enzyme that promotes translation through modified uridine regulation. | J Biol Chem | 2023 | 37507018 | PubTator, text mining | PubMed |
| Characterization of epitranscriptome reader proteins experimentally and in silico: Current knowledge and future perspectives beyond the YTH domain. | Comput Struct Biotechnol J | 2023 | 37501707 | PubTator, text mining | PubMed |
| Significance of methylation-related genes in diagnosis and subtype classification of renal interstitial fibrosis. | Hereditas | 2023 | 37496082 | PubTator, text mining | PubMed |
| Searching for molecular hypoxia sensors among oxygen-dependent enzymes. | Elife | 2023 | 37494095 | PubTator, text mining | PubMed |
| Multilevel regulation of N6-methyladenosine RNA modifications: Implications in tumorigenesis and therapeutic opportunities. | Genes Dis | 2023 | 37492716 | PubTator, text mining | PubMed |
| Therapeutic Applications of Azanucleoside Analogs as DNA Demethylating Agents. | Epigenomes | 2023 | 37489400 | PubTator, text mining | PubMed |
| Unraveling the interplay between norovirus infection, gut microbiota, and novel antiviral approaches: a comprehensive review. | Front Microbiol | 2023 | 37485533 | PubTator, text mining | PubMed |
| Novel insight into RNA modifications in tumor immunity: Promising targets to prevent tumor immune escape. | Innovation (Camb) | 2023 | 37485079 | PubTator, text mining | PubMed |
| N6-methyladenosine RNA modification: an emerging molecule in type 2 diabetes metabolism. | Front Endocrinol (Lausanne) | 2023 | 37484964 | PubTator, text mining | PubMed |
| The role of m5C methyltransferases in cardiovascular diseases. | Front Cardiovasc Med | 2023 | 37476573 | PubTator, text mining | PubMed |
| The disordered C terminus of ALKBH5 promotes phase separation and paraspeckles assembly. | J Biol Chem | 2023 | 37474102 | PubTator, text mining | PubMed |
| Role of N6-methyladenosine RNA modification in gastric cancer. | Cell Death Discov | 2023 | 37443100 | PubTator, text mining | PubMed |
| Association between ABO blood groups and SARS-CoV-2 infection in blood donors of Puglia region. | Ann Hematol | 2023 | 37442822 | PubTator, text mining | PubMed |
| A rare report of H-partially deficient, non-secretor phenotype from India. An Ah like the rèunion and unlike a Para Bombay-Clarifying misinterpretations. | Transfus Apher Sci | 2023 | 37442661 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8846/papers?page=17